A novel function of CD40: Induction of cell death in transformed cells

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 159-167

  Hess, Sigrun ^a   Engelmann, Hartmut ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute for Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL TRANSFORMATION; CYTOTOXICITY; HAMSTER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPITHELIAL CELLS; EPITHELIUM; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-1; MESODERM; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030067795     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.159     Document Type: Article

References (68)

1. Nossal, G.J.V. 1994. Negative selection of lymphocytes. Cell. 76.229-239.
2. Henkart, P.A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1:343-346.
3. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 10709-10715.
4. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
5. Loetscher, H., Y.-C.E. Pan, H.-W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351-359.
6. Schall, T.J., M. Lewis, K.J. Koller, A. Lee, G.C. Rice, G.H.W. Wong, T. Gatanaga, G.A. Granger, R. Lentz, H. Raab, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:361-370.
7. Nophar, Y., O. Kemper, C. Brakebusch, H Engelmann, R. Zwang, D. Aderka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R cloned using amino acid data of its soluble form, encodes for both the cell surface and a soluble form of the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:3269-3278.
8. Sugarman, B.J., B.B. Aggarwal, P.E. Mass, I.S. Figari, M.A.J. Palladino, and H.M. Shepard. 1985. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science (Wash. DC). 230:943-945.
9. Tartaglia, L.A., T.M. Ayres, G.H. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:845-853.
10. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932-10937.
11. Scamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol. Organ.) J. 8:1403-1410.
12. Liu, Y.J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature (Lond.). 342:929-931.
13. Gregory, C.D., C Dive, S. Henderson, C.A. Smith, G.T. Williams, J. Gordon, and A.B. Rickinson. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (Lond.). 349:612-614.
14. Valentine, M.A., and K.A. Licciardi. 1992. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur. J. Immunol. 22:3141-3148.
15. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357:80-82.
16. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, A.S. Braesch, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11: 4313-4321.
17. Graf, D., U. Korthäuer, H.W. Mages, G. Senger, and R.A. Kroczek. 1992. Cloning of TRAP, a iigand for CD40 on human T cells. Eur. J. Immunol. 22:3191-3194.
18. Jabara, H.H., S.M. Fu, R.S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861-1864.
19. Clark, E.A., and J.A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA. 83: 4494-4498.
20. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (Wash. DC). 251:70-72.
21. Barrett, T.B., G. Shu, and E.A. Clark. 1991. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722-1729.
22. Ranheim, E.A., and T.J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925-935.
23. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300.
24. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990-993.
25. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:541-543.
26. Korthäuer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, A G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539-541.
27. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani, 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
28. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
29. Lane, P.J., J.A. Ledbetter, P.M. McConnell, K. Draves, J. Deans, G.L. Schieven, and E.A. Clark. 1991 The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release. J. Immunol. 146:715-722.
30. Uckun, F.M., G.L. Schieven, I. Dibirdik, L.M. Chandan. A.L. Tuel, and J.A. Ledbetter. 1991. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny J Biol Chem. 266:17478-17485.
31. Ren, C.L., T. Morio, S.M. Fu, and R.S. Geha. 1994. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179:673-680.
32. Hu, H.M., K. O'Rourke, M.S. Boguski, and V.M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
33. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:389-399.
34. Sato, T., S. Irie, and J.C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett 358:113-118.
35. Cheng, G., A.M Cleary, Z.-s. Ye, D.I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science (Wash. DC). 267:1494-1498.
36. Hart, D.N.J., and J.L. McKenzie. 1988. Isolation and characterization of human tonsil dendritic cells. J. Exp. Med. 168: 157-170.
37. Galy, A.H., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149:775-782.
38. Paulie, S., B. Ehlin-Henricksson, H. Mellstadt, H. Koho, H. Ben-Aissa, and P. Perlmann. 1985. A p50 surface antigen restricted to urinary bladder carcinomas and B-lymphocytes. Cancer Immunol. Immunother. 20:23-28.
39. Ledbetter, J.A., E.A. Clark, N.A. Norris, G. Shu, and I. Hellström. 1987. Expression of a Functional B-Cell Receptor CDw40 (Bp50) on Carcinomas. A.J. MacMichael, P.C.L. Beverly, W. Gilks, M. Horton, D.Y. Mason, S. Cobbold, F.M. Gotch, N. Ling, C. Milstein, H. Waldmann, et al., editors. Oxford University Press, Oxford. 432-435.
40. Young, L.S., C.W. Dawson, K.W. Brown, and A.B. Rickinson. 1989. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int. J. Cancer. 43:786-794.
41. Hess, S., A. Rensing-Ehl, R. Schwabe, P. Bufler, and H. Engelmann. 1995. CD40 function in nonhematopoietic cells. NF-κB mobilization and IL-6 production. J. Immunol. 55: 4588-4595.
42. Rensing-Ehl, A., S. Hess, H.W.L. Ziegler-Heitbrock, G. Riethmuller, and H. Engelmann. 1994. Fas/Apo-1 activates NF-κB and induces IL-6 production. J. Inflammation. 45:161-174.
43. Littlefield, J.W. 1964. Three degrees of guanylic acid-inosinic acid pyrophosphorylase deficiency in mouse fibroblasts. Nature (Lond.). 203:1142.
44. Todaro, J.G., H. Green, and M.R. Swift. 1966. Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science (Wash. DC). 153:1252-1254.
45. Hess, S., R. Kurrle, L. Lauffler, G. Riethmüller, and H. Engelmann. 1995. A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on Herpesvirus saimiri-transformed T cells. Eur. J. Immunol. 25:80-86.
46. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Adds Res. 18:5322.
47. Brockhaus, M., H.-J. Schoenfeld, E.J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on different cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 87.3127-3131.
48. Finter, N.B. 1969. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. Gen Virol. 5:419-427.
49. Wallach, D. 1984. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol. 132:2464-2469.
50. Lewis, M., L.A. Tartaglia, A. Lee, G.L. Bennett, G.C. Rice, G.H. Wong, E.Y. Chen, and D.V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA. 88:2830-2834.
51. Rensing-Ehl, A., S. Hess, H.W.L. Ziegler-Heitbrock, G. Riethmüller, and H. Engelmann. 1994. Fas and TNF receptor p55 use different signalling pathways for cell death but activate NF-κB via identical routes. Eur Cytokine Netw. 5:105 (Abstr.).
52. Wong, G.H., and D.V. Goeddel. 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science (Wash. DC). 242:941-944.
53. Kumar, S., and C. Baglioni. 1991. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960-20964.
54. Opipari, A.W., H.M. Hu, R. Yabkowitz, and V.M. Dixit. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem 267:12424-12427.
55. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO (Eur. Mol. Biol. Organ.) J. 12:3095-3104.
56. Schulze-Osthoff, K., P.H. Krammer, and W. Dröge. 1994. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO (Eur. Mol. Biol. Organ.) J. 13:4587-4596.
57. Clark, E.A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature (Lond.). 367:425-428.
58. Wong, G.H.W., and D. Goeddel. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751-1755.
59. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-7798.
60. Hsu, H., J. Xiong, and D.V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:495-504.
61. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
62. Stanger, B.Z., P. Leder, T.-H. Lee, E. Kim, and B. Seed. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:513-523.
63. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.). 375:78-81.
64. Los, M., M. Van de Craen, L.C. Penning, H. Schenk, M. Westendorp, P. Baeuerle, W. Dröge, P.H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.). 375:81-83.
65. Kägi, D., F. Vignaux, B. Ledermann, K. Birki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
66. Williamson, B.D., E.A. Carswell, B.Y. Rubin, J.S. Prendergast, and L.J. Old. 1983. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl. Acad. Sci. USA. 80:5397-5401.
67. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med 169:1747-1756.
68. Sato, T., S. Irie, S. Kitada, and J.C. Reed. 1995. FAP-1: a protein tyrosine phospharase that associates with Fas. Science (Wash. DC). 268:411-415.